FDAFDA · Food and drugs·Recall number D-607-2013
Norpace CR (disopyramide phosphate) extended-release capsules USP,150 mg, packaged in a) 100-count bottles (NDC 0025-2742-31), and b) 500-count bottles (NDC 0025-2742-51), Rx only, Distributed by G.D. Searle LLC, Division of Pfizer Inc, NY, NY 10017.
Published June 26, 2013 · Recall initiated: May 31, 2013
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specification
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- NORPACE CR
- Manufacturer
- Pfizer Inc
- Distributor
- Nationwide and Puerto Rico
- UPC
- 0300252752314
- Lot
- Lot #: a) C120138, Exp 07/13; b) C120137, Exp 07/13
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.